Ownership history in CITIGROUP INC · 17 quarters on record
This page tracks every 13F SEC filing in which CITIGROUP INC reported a position in ACUMEN PHARMACEUTICALS INC (ABOS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 151 | -2,964 | -95.2% | 0.00% | $258 | $1.71 |
| 2025 Q2 | REDUCED | 3,115 | -26,721 | -89.6% | 0.00% | $4K | $1.16 |
| 2025 Q1 | REDUCED | 29,836 | -50,509 | -62.9% | 0.00% | $33K | $1.10 |
| 2024 Q4 | ADDED | 80,345 | +49,753 | +162.6% | 0.00% | $138K | $1.72 |
| 2024 Q3 | ADDED | 30,592 | +21,177 | +224.9% | 0.00% | $76K | $2.48 |
| 2024 Q2 | REDUCED | 9,415 | -125,979 | -93.0% | 0.00% | $23K | $2.42 |
| 2024 Q1 | REDUCED | 135,394 | -12,417 | -8.4% | 0.00% | $548K | $4.05 |
| 2023 Q4 | ADDED | 147,811 | +109,313 | +283.9% | 0.00% | $568K | $3.84 |
| 2023 Q3 | ADDED | 38,498 | +37,801 | +5423.4% | 0.00% | $160K | $4.15 |
| 2023 Q2 | REDUCED | 697 | -40,680 | -98.3% | 0.00% | $3K | $4.81 |
As of 2025 Q4 — sorted by position size